[Cardioactive agents. 49].
D001224:Aspartic Acid / Q000494:pharmacology; D002018:Bufanolides / Q000032:analysis / Q000494:pharmacology; D002297:Cardanolides / Q000032:analysis / Q000494:pharmacology; D002301:Cardiac Glycosides / Q000009:adverse effects / Q000032:analysis / Q000494:pharmacology*; D004074:Digitoxin / Q000627:therapeutic use; D004077:Digoxin / Q000494:pharmacology; D006321:Heart / Q000187:drug effects*; D006331:Heart Diseases / Q000188:drug therapy*; D006801:Humans; D007666:Khellin / Q000494:pharmacology; D007799:Lanatosides / Q000032:analysis / Q000494:pharmacology; D009573:Nitrites / Q000494:pharmacology; D010946:Plants, Medicinal / Q000302:isolation & purification / Q000494:pharmacology; D011342:Procainamide / Q000494:pharmacology; D011802:Quinidine / Q000494:pharmacology; D013328:Strophanthins / Q000494:pharmacology; D013565:Sympatholytics / Q000494:pharmacology; D013566:Sympathomimetics / Q000494:pharmacology; D014665:Vasodilator Agents / Q000494:pharmacology
D002018:Bufanolides; D002297:Cardanolides; D002301:Cardiac Glycosides; D007799:Lanatosides; D009573:Nitrites; D013328:Strophanthins; D013565:Sympatholytics; D013566:Sympathomimetics; D014665:Vasodilator Agents; D001224:Aspartic Acid; D007666:Khellin; D004077:Digoxin; D004074:Digitoxin; D011802:Quinidine; D011342:Procainamide
Kardiaka. 49.